Recent advances in application of computer-aided drug design in anti-COVID-19 Virials Drug Discovery.

Corona Virus Disease 2019 (COVID-19) is a global pandemic epidemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), which poses a serious threat to human health worldwide and results in significant economic losses. With the continuous emergence of new virus strains, small molecule drugs remain the most effective treatment for COVID-19. The traditional drug development process usually requires several years; however, the development of computer-aided drug design (CADD) offers the opportunity to develop innovative drugs quickly and efficiently. The literature review describes the general process of CADD, the viral proteins that play essential roles in the life cycle of SARS-CoV-2 and can serve as therapeutic targets, and examples of drug screening of viral target proteins by applying CADD methods. Finally, the potential of CADD in COVID-19 therapy, the deficiency, and the possible future development direction are discussed. Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Citation

Weiying Yang, Ye Wang, Dongfeng Han, Wenjing Tang, Lichao Sun. Recent advances in application of computer-aided drug design in anti-COVID-19 Virials Drug Discovery. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2024 Apr;173:116423

Mesh Tags

Substances

PMID: 38493593

search → result